Ray Dalio started to build up the position in OptimizeRx in Q3 2021 and continued to invest until Q2 2022. Since then they sold 46.1 Thousand shares. The investor completely sold their stake between Q3 2022 and Q4 2022.
Avg closing price
Price range
Sold -19.2 Thousand shares
Q4 2022
Avg closing price
$17.29
Price range
$13.77
-
$22.04
Sold 58.4% shares (-26.9 Thousand shares)
Q3 2022
Avg closing price
$19.77
Price range
$13.74
-
$30.13
Increased shares by 6.9% (+3 Thousand shares)
Q2 2022
Avg closing price
$29.63
Price range
$21.94
-
$40.49
Increased shares by 31.9% (+10.4 Thousand shares)
Q1 2022
Avg closing price
$44.26
Price range
$35.27
-
$62.91
Increased shares by 14.5% (+4.15 Thousand shares)
Q4 2021